Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Avash Kalra

Concepts (49)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
4
2018
872
1.280
Why?
End Stage Liver Disease
3
2018
82
1.120
Why?
Liver Neoplasms
2
2018
786
0.690
Why?
Waiting Lists
3
2018
262
0.680
Why?
Hepatitis, Autoimmune
1
2018
20
0.600
Why?
Resource Allocation
1
2018
51
0.560
Why?
Lymphocytes
1
2017
395
0.450
Why?
Graft Rejection
1
2018
623
0.450
Why?
Liver Cirrhosis
1
2017
316
0.440
Why?
Tissue and Organ Procurement
1
2018
314
0.440
Why?
Glucocorticoids
1
2018
599
0.430
Why?
Carcinoma, Hepatocellular
1
2016
360
0.390
Why?
Neutrophils
1
2017
1238
0.350
Why?
Adenocarcinoma, Mucinous
1
2023
80
0.190
Why?
Organ Transplantation
1
2023
248
0.160
Why?
Carcinoma, Pancreatic Ductal
1
2023
291
0.160
Why?
Withholding Treatment
1
2018
76
0.140
Why?
Lymphocyte Count
1
2017
150
0.130
Why?
Tissue Donors
1
2018
417
0.120
Why?
Pancreatic Neoplasms
1
2023
943
0.110
Why?
Gastrointestinal Agents
1
2014
65
0.110
Why?
Multivariate Analysis
1
2017
1524
0.100
Why?
Colitis
1
2014
265
0.090
Why?
Autoimmune Diseases
1
2014
459
0.080
Why?
Case-Control Studies
1
2017
3546
0.080
Why?
Severity of Illness Index
1
2017
2838
0.070
Why?
Prognosis
1
2017
4031
0.070
Why?
Time Factors
1
2018
6817
0.070
Why?
Antibodies, Monoclonal
1
2014
1428
0.070
Why?
Humans
6
2023
137514
0.060
Why?
Biomarkers
1
2017
4172
0.060
Why?
Treatment Outcome
1
2018
10821
0.050
Why?
Antineoplastic Agents
1
2014
2145
0.050
Why?
Risk Factors
1
2017
10356
0.050
Why?
United States
1
2018
14696
0.040
Why?
Pancreas
1
2023
328
0.040
Why?
Prevalence
1
2023
2719
0.030
Why?
Middle Aged
1
2017
33355
0.030
Why?
Ipilimumab
1
2014
34
0.030
Why?
Infliximab
1
2014
110
0.030
Why?
Diarrhea
1
2014
183
0.030
Why?
Hypotension
1
2014
123
0.030
Why?
Male
2
2017
67718
0.020
Why?
Female
1
2017
73162
0.020
Why?
Critical Illness
1
2014
809
0.020
Why?
Melanoma
1
2014
758
0.020
Why?
Acute Kidney Injury
1
2014
811
0.020
Why?
Retrospective Studies
1
2023
15628
0.010
Why?
Aged
1
2014
23798
0.010
Why?
Kalra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)